Efficacy of co-medications in patients with alcoholic liver disease

Background: Alcoholic liver disease (ALD) is still increasing and leads to acute liver injury but also liver cirrhosis and subsequent complications such as liver failure or hepatocellular carcinoma (HCC). As most patients fail to achieve alcohol abstinence, it is essential to identify alternative tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Itzel, Timo (VerfasserIn) , Falconer, Thomas (VerfasserIn) , Roig, Ana (VerfasserIn) , Daza Barragán, Jimmy Andres (VerfasserIn) , Park, Jimyung (VerfasserIn) , Cheong, Jae Youn (VerfasserIn) , Park, Rae Woong (VerfasserIn) , Wiest, Isabella (VerfasserIn) , Ebert, Matthias (VerfasserIn) , Hripcsak, George (VerfasserIn) , Teufel, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2023
In: Digestive diseases
Year: 2023, Jahrgang: 41, Heft: 5, Pages: 780-788
ISSN:1421-9875
DOI:10.1159/000529914
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000529914
Verlag, lizenzpflichtig, Volltext: https://karger.com/ddi/article/41/5/780/853508/Efficacy-of-Co-Medications-in-Patients-with
Volltext
Verfasserangaben:Timo Itzel, Thomas Falconer, Ana Roig, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias P. Ebert, George Hripcsak, Andreas Teufel

MARC

LEADER 00000caa a2200000 c 4500
001 1902252942
003 DE-627
005 20241205171305.0
007 cr uuu---uuuuu
008 240910s2023 xx |||||o 00| ||eng c
024 7 |a 10.1159/000529914  |2 doi 
035 |a (DE-627)1902252942 
035 |a (DE-599)KXP1902252942 
035 |a (OCoLC)1475311374 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Itzel, Timo  |d 1979-  |e VerfasserIn  |0 (DE-588)1196136319  |0 (DE-627)1677983841  |4 aut 
245 1 0 |a Efficacy of co-medications in patients with alcoholic liver disease  |c Timo Itzel, Thomas Falconer, Ana Roig, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias P. Ebert, George Hripcsak, Andreas Teufel 
264 1 |c September 2023 
300 |b Illustrationen 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 26. Juni 2023 
500 |a Gesehen am 10.09.2024 
520 |a Background: Alcoholic liver disease (ALD) is still increasing and leads to acute liver injury but also liver cirrhosis and subsequent complications such as liver failure or hepatocellular carcinoma (HCC). As most patients fail to achieve alcohol abstinence, it is essential to identify alternative treatment options in order to improve the outcome of ALD patients. Methods: Evaluating two large cohorts of patients with ALD from the USA and Korea with a total of 12,006 patients, we investigated the effect on survival of aspirin, metformin, metoprolol, dopamine, and dobutamine drugs in patients with ALD between 2000 and 2020. Patient data were obtained through the “The Observational Health Data Sciences and Informatics consortium,” an open-source, multi-stakeholder, and interdisciplinary collaborative effort. Results: The use of aspirin (p = 0.000, p = 0.000), metoprolol (p = 0.002, p = 0.000), and metformin (p = 0.000, p = 0.000) confers a survival benefit for both AUSOM- and NY-treated cohorts. Need of catecholamines dobutamine (p = 0.000, p = 0.000) and dopamine (p = 0.000, p = 0.000) was strongly indicative of poor survival. β-Blocker treatment with metoprolol (p = 0.128, p = 0.196) or carvedilol (p = 0.520, p = 0.679) was not shown to be protective in any of the female subgroups. Conclusion: Overall, our data fill a large gap in long-term, real-world data on patients with ALD, confirming an impact of metformin, acetylsalicylic acid, and β-blockers on ALD patient’s survival. However, gender and ethnic background lead to diverse efficacy in those patients. 
700 1 |a Falconer, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Roig, Ana  |e VerfasserIn  |4 aut 
700 1 |a Daza Barragán, Jimmy Andres  |d 1990-  |e VerfasserIn  |0 (DE-588)1237697921  |0 (DE-627)176462193X  |4 aut 
700 1 |a Park, Jimyung  |e VerfasserIn  |4 aut 
700 1 |a Cheong, Jae Youn  |e VerfasserIn  |4 aut 
700 1 |a Park, Rae Woong  |e VerfasserIn  |4 aut 
700 1 |a Wiest, Isabella  |d 1992-  |e VerfasserIn  |0 (DE-588)1198882956  |0 (DE-627)168103638X  |4 aut 
700 1 |a Ebert, Matthias  |d 1968-  |e VerfasserIn  |0 (DE-588)1030133522  |0 (DE-627)734827083  |0 (DE-576)377938432  |4 aut 
700 1 |a Hripcsak, George  |e VerfasserIn  |4 aut 
700 1 |a Teufel, Andreas  |d 1971-  |e VerfasserIn  |0 (DE-588)121120031  |0 (DE-627)081100035  |0 (DE-576)292546750  |4 aut 
773 0 8 |i Enthalten in  |t Digestive diseases  |d Basel : Karger, 1985  |g 41(2023), 5, Seite 780-788  |h Online-Ressource  |w (DE-627)300191294  |w (DE-600)1482221-0  |w (DE-576)112438164  |x 1421-9875  |7 nnas  |a Efficacy of co-medications in patients with alcoholic liver disease 
773 1 8 |g volume:41  |g year:2023  |g number:5  |g pages:780-788  |g extent:9  |a Efficacy of co-medications in patients with alcoholic liver disease 
856 4 0 |u https://doi.org/10.1159/000529914  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://karger.com/ddi/article/41/5/780/853508/Efficacy-of-Co-Medications-in-Patients-with  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240910 
993 |a Article 
994 |a 2023 
998 |g 121120031  |a Teufel, Andreas  |m 121120031:Teufel, Andreas  |d 60000  |d 61100  |e 60000PT121120031  |e 61100PT121120031  |k 0/60000/  |k 1/60000/61100/  |p 11  |y j 
998 |g 1030133522  |a Ebert, Matthias  |m 1030133522:Ebert, Matthias  |d 60000  |d 61100  |e 60000PE1030133522  |e 61100PE1030133522  |k 0/60000/  |k 1/60000/61100/  |p 9 
998 |g 1198882956  |a Wiest, Isabella  |m 1198882956:Wiest, Isabella  |d 60000  |d 61100  |e 60000PW1198882956  |e 61100PW1198882956  |k 0/60000/  |k 1/60000/61100/  |p 8 
998 |g 1237697921  |a Daza Barragán, Jimmy Andres  |m 1237697921:Daza Barragán, Jimmy Andres  |d 60000  |d 61100  |e 60000PD1237697921  |e 61100PD1237697921  |k 0/60000/  |k 1/60000/61100/  |p 4 
998 |g 1196136319  |a Itzel, Timo  |m 1196136319:Itzel, Timo  |d 60000  |d 61100  |e 60000PI1196136319  |e 61100PI1196136319  |k 0/60000/  |k 1/60000/61100/  |p 1  |x j 
999 |a KXP-PPN1902252942  |e 4578507335 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"noteIll":"Illustrationen","extent":"9 S."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Efficacy of co-medications in patients with alcoholic liver disease","title":"Efficacy of co-medications in patients with alcoholic liver disease"}],"person":[{"family":"Itzel","given":"Timo","role":"aut","display":"Itzel, Timo"},{"family":"Falconer","role":"aut","given":"Thomas","display":"Falconer, Thomas"},{"display":"Roig, Ana","family":"Roig","role":"aut","given":"Ana"},{"family":"Daza Barragán","given":"Jimmy Andres","role":"aut","display":"Daza Barragán, Jimmy Andres"},{"role":"aut","given":"Jimyung","family":"Park","display":"Park, Jimyung"},{"display":"Cheong, Jae Youn","given":"Jae Youn","role":"aut","family":"Cheong"},{"display":"Park, Rae Woong","given":"Rae Woong","role":"aut","family":"Park"},{"display":"Wiest, Isabella","role":"aut","given":"Isabella","family":"Wiest"},{"display":"Ebert, Matthias","family":"Ebert","given":"Matthias","role":"aut"},{"display":"Hripcsak, George","given":"George","role":"aut","family":"Hripcsak"},{"display":"Teufel, Andreas","given":"Andreas","role":"aut","family":"Teufel"}],"recId":"1902252942","name":{"displayForm":["Timo Itzel, Thomas Falconer, Ana Roig, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias P. Ebert, George Hripcsak, Andreas Teufel"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"September 2023"}],"id":{"doi":["10.1159/000529914"],"eki":["1902252942"]},"note":["Online veröffentlicht: 26. Juni 2023","Gesehen am 10.09.2024"],"relHost":[{"disp":"Efficacy of co-medications in patients with alcoholic liver diseaseDigestive diseases","recId":"300191294","part":{"pages":"780-788","volume":"41","extent":"9","text":"41(2023), 5, Seite 780-788","year":"2023","issue":"5"},"id":{"doi":["10.1159/issn.0257-2753"],"issn":["1421-9875"],"zdb":["1482221-0"],"eki":["300191294"]},"origin":[{"dateIssuedKey":"1985","publisher":"Karger","dateIssuedDisp":"1985-","publisherPlace":"Basel"}],"pubHistory":["Vol. 3, no. 4 (1985)-"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"corporate":[{"display":"European Association for Gastroenterology, Endoscopy and Nutrition","role":"isb"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 16.09.25","Titelzusatz früher: current reviews in research and practice ; state-of-the-art clinical reviews"],"title":[{"title_sort":"Digestive diseases","title":"Digestive diseases"}]}]} 
SRT |a ITZELTIMOFEFFICACYOF2023